Most symptomatic patients have total villous atrophy
Defined as completely flattened villi
Partial atrophy more common in pre-symptomatic or post-treatment patients or in relatives being screened
Increased intraepithelial lymphocytes in small intestine may be seen with or without atrophy
Cutoff varies by location
Duodenum >30 / 100 enterocytes
Alternative proposed is 6-12 / 20 enterocytes at the tips of villi
Jejunum >40 / 100 enterocytes
Occasionally seen in stomach and large intestine
T cell phenotype
CD2+, CD3+, CD8 70-90%
Gamma delta T cell receptor
CD3 stain is useful for identification and counting
Intraepithelial lymphocytes evenly distributed from bottom to top of crypts or increased at tops
Normal distribution is decreasing from bottom to top
Villi must be well oriented to be certain that what appears to be the top is not a semi-tangentially cut section of mid-villus
Identification of an abnormal distribution or of more than rare lymphocytes on H&E is a clue that it may be worth staining and counting cells
Increased intraepithelial lymphocytes in the absence of villus atrophy is suggestive of latent or partially treated celiac disease but not specific, as it can be seen in:
Simplified systems (Corazza, Roberts, Ensari) may be more reproducible
Grade A/Type 1: increased intraepithelial lymphocytes but no villous atrophy
Grade B1/Type 2: villi still present but shortened
Grade B2/Type 3: complete villous atrophy
Robert V Rouse MD
Department of Pathology
Stanford University School of Medicine
Stanford CA 94305-5342
Original posting, last update: 11/11/09, 12/3/14
Modified Marsh Classification of histologic findings in celiac disease (Oberhuber)
Marsh Type
IEL / 100 enterocytes – jejunum
IEL / 100 enterocytes - duodenum
Crypt hyperplasia
Villi
0
<40
<30
Normal
Normal
1
>40
>30
Normal
Normal
2
>40
>30
Increased
Normal
3a
>40
>30
Increased
Mild atrophy
3b
>40
>30
Increased
Marked atrophy
3c
>40
>30
Increased
Complete atrophy
IEL/100 enterocytes, intraepithelial lymphocytes per 100 enterocytes
Type 0: Normal; celiac disease highly unlikely.
Type 1: Seen in patients on gluten free diet (suggesting minimal amounts of gluten or gliadin are being ingested); patients with dermatitis herpetiformis; family members of celiac disease patients, not specific, may be seen in infections.
Type 2: Very rare, seen occasionally in dermatitis herpetiformis.
Type 3: Spectrum of changes seen in symptomatic celiac disease.
Simplified systems may be more reproducible (Corazza, Roberts, Ensari)
Grade A/Type 1: increased intraepithelial lymphocytes but no villous atrophy
Seen in patients on gluten free diet (suggesting minimal amounts of gluten or gliadin are being ingested); patients with dermatitis herpetiformis; family members of celiac disease patients, not specific, may be seen in infections
Grade B1/Type 2: villi still present but shortened
Spectrum of changes seen in symptomatic celiac disease
Grade B2/Type 3: complete villous atrophy
Spectrum of changes seen in symptomatic celiac disease
Supplemental studies
Immunohistology
CD3 or other pan-T cell marker is useful for identifying and counting T cells
Serology
Quite sensitive and specific
Especially useful for screening
As 3% of celiac disease patients are IgA deficient, biopsy is necessary to rule out disease
Usually begins under 6 months of age, but can occur in adults
Responds to gluten withdrawal
Refractory to gluten withdrawal
Anti-endomysial and - tissue transglutaminase antibodies
Anti-enterocyte antibodies
CD4 negative T cells predominate
CD4+ T cells predominate
Gamma delta T cell receptors predominate
Alpha beta T cell receptors predominate
For pediatric autoimmune enteropathy with associated polyendocrinopathy see IPEX syndrome.
Some adult autoimmune enteropathy cases have been discovered in the workup of patients thought to have celiac disease but who do not respond to removal of gluten from the diet
Some of these can occur even in patients with sub-clinical celiac disease
Gluten free diet can resolve or decrease the risk of occurrence of these disorders
Bibliography
Noffsinger A, Fenoglio-Preiser CM, Maru D, Gilinisky N. Gastrointestinal Diseases, AFIP Atlas of Nontumor Pathology, First Series, Fascicle 5, 2007.
Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol. 1999 Oct;11(10):1185-94.
Corazza GR, Villanacci V, Zambelli C, Milione M, Luinetti O, Vindigni C, Chioda C, Albarello L, Bartolini D, Donato F. Comparison of the interobserver reproducibility with different histologic criteria used in celiac disease. Clin Gastroenterol Hepatol. 2007 Jul;5(7):838-43.
Di Sabatino A, Corazza GR. Coeliac disease. Lancet. 2009 Apr 25;373(9673):1480-93.
Ensari A. Gluten-sensitive enteropathy (celiac disease): controversies in diagnosis and classification. Arch Pathol Lab Med. 2010 Jun;134(6):826-36.
Robert ME. Gluten sensitive enteropathy and other causes of small intestinal lymphocytosis. Semin Diagn Pathol. 2005 Nov;22(4):284-94.
Brown I, Mino-Kenudson M, Deshpande V, Lauwers GY. Intraepithelial lymphocytosis in architecturally preserved proximal small intestinal mucosa: an increasing diagnostic problem with a wide differential diagnosis. Arch Pathol Lab Med. 2006 Jul;130(7):1020-5.
Walker MM, Murray JA. An update in the diagnosis of coeliac disease. Histopathology. 2011 Aug;59(2):166-79.
Moran CJ, Kolman OK, Russell GJ, Brown IS, Mino-Kenudson M. Neutrophilic infiltration in gluten-sensitive enteropathy is neither uncommon nor insignificant: assessment of duodenal biopsies from 267 pediatric and adult patients. Am J Surg Pathol. 2012 Sep;36(9):1339-45